1. Westerfield J, Holcomb S, Jensen S (eds). Current Trends in Diabetes Management: A Guide for the Healthcare Professional. 7th ed. Nashville, TN: Healthways; 2008.
2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
3. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program. Available athttps://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-dpp. Last accessed February 6, 2023.
4. Davis SN, Mann S, Briscoe VJ, Ertl AC, Tate DB. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes. 2009;58(3):701-709.
5. American Diabetes Association. Standards of medical care in diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10-38.
6. Bonaventura A, Montecucco F, Dallegri F. Update on strategies limiting iatrogenic hypoglycemia. Endocr Connect. 2015;4(3):R37-R45.
7. Martorella AJ. Iatrogenic hypoglycemia in patients with type 2 diabetes: comparison of insulin analog premixes and human insulin premixes. Postgrad Med. 2011;123(4):7-16.
8. Wolfsdorf JI, Weinstein DA. Hypoglycemia in children. In: Lifshitz F (ed). Pediatric Endocrinology Volume 1: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia. 5th ed. New York, NY: Informa Healthcare; 2007: 291-328.
10. Briscoe VJ, Davis SN. Hypoglycemia in type 1 and type 2 diabetes: physiology, pathophysiology, and management. Clin Diabetes. 2006;24(3):115-121.
11. Lee MH, Ward GM, MacIsaac RJ, et al. Mortality in people with type 1 diabetes, severe hypoglycemia, and impaired awareness of hypoglycemia referred for islet transplantation. Transplant Direct. 2018;4(11):e401.
12. Cryer PE. Hypoglycemia in type 2 diabetes. In: Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008: 227-236.
13. Hamdy O. Hypoglycemia. Available at https://emedicine.medscape.com/article/122122-overview#a1. Last accessed February 6, 2023.
14. Bardsely JK, Ratner RE. Pathophysiology of the metabolic disorder. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
15. Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer, PE. Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes. 2008;57(2):470-475.
16. 16. Schneider CA, Erdman E. Acute coronary syndrome, myocardial infarction, heart failure, and stable coronary artery disease: specific consideration in diabetes. In: Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008: 463-474.
17. Eise T, Hammer GD. Disorders of the adrenal medulla. In: McPhee SJ, Hammer GD (eds). Pathophysiology of Disease: An Introduction to Clinical Medicine. 7th ed. New York, NY: McGraw Hill; 2014: 319-332.
18. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592-3601.
19. Fioramonti X, Fakira K, Beluch N, et al. Role of Hypothalamic S-Nitrosylation in the Development of Hypoglycemia-Associated Autonomic Failure (HAAF): Insight for Therapy [abstract]. Available athttps://professional.diabetes.org/abstract/role-hypothalamic-s-nitrosylation-development-hypoglycemia-associated-autonomic-failure. Last accessed February 6, 2023.
20. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998;338(23):1657-1662.
21. Walsh J, Roberts R. Pumping Insulin: Everything You Need for Success with a Pump and CGM. 6th ed. San Diego, CA: Torrey Pine Press; 2016.
22. Kulkarni K. Monitoring. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
23. Choudhary P, Rickels MR, Senior PA, et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care. 2015;38(6):1016-1029.
24. Davis TM, Brown SG, Jacobs IG. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab. 2010;95:2240-2247.
25. Freeman J, Franz MJ. Medical nutrition therapy. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
26. Spollett GR. Type 2 diabetes across the life span. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
27. de Galan BE, Zoungas S, Chalmers J. Cognitive function and risks of cardiovascular disease and hypoglycemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2009;52:2328-2336.
28. Seligman HK, Davis TC, Schillinger D, Wolf MS. Food insecurity is associated with hypoglycemia and poor diabetes self-management in a low-income sample with diabetes. J Health Care Poor Underserved. 2010;21:1227-1233.
29. Katon WJ, Young BA, Russo J, et al. Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Intern Med. 2013;11(3):245-250.
30. Jou J, Johnson PJ. Nondisclosure of complementary and alternative medicine use to primary care physicians: findings from the 2012 National Health Interview Survey. JAMA Intern Med. 2016;176(4):545-546.
31. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2003;25(2):324-329.
32. Shane-McWhorter L. Botanical dietary supplements and the treatment of diabetes: what is the evidence? Curr Diab Rep. 2005;5(5):391-398.
33. Sisson E. AADE Quick Guide to Medications. 9th ed. Chicago, IL: American Association of Diabetes Educators; 2019.
34. Akilen R, Tsiami A, Devendra D, Robinson N. Cinnamon in glycaemic control: systematic review and meta-analysis. Clin Nutr. 2012;31(5):609-615.
35. Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008;31(1):41-43.
36. National Center for Complementary and Alternative Medicine. Herbs At A Glance: Fenugreek. Available athttps://nccih.nih.gov/health/fenugreek. Last accessed February 6, 2023.
37. 37. Sasa M, Inoue I, Shinoda Y, et al. Activating effect of momordin, extract of bitter melon on the promoter of human PPARdelta. J Atheroscler Thromb. 2009;1696:888-892.
38. Joseph B, Jini D, Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013;3(2):93-102.
39. National Center for Complementary and Alternative Medicine. Asian Ginseng. Available athttps://nccih.nih.gov/health/asianginseng/ataglance.htm. Last accessed February 6, 2023.
40. WebMD. Prickly Pear Cactus. Available athttps://www.webmd.com/vitamins/ai/ingredientmono-880/prickly-pear-cactus. Last accessed February 6, 2023.
41. National Center for Complementary and Alternative Medicine. Aloe Vera. Available athttps://nccih.nih.gov/health/aloe-vera. Last accessed February 6, 2023.
42. National Center for Complementary and Alternative Medicine. Bilberry. Available athttps://nccih.nih.gov/health/bilberry. Last accessed February 6, 2023.
43. National Center for Complementary and Alternative Medicine. Milk Thistle. Available athttps://nccih.nih.gov/health/milk-thistle. Last accessed February 6, 2023.
44. Mensing C. The role of the diabetes educator in the education and management of diabetes mellitus. In: Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 3rd ed. New York, NY: Informa Healthcare; 2014.
45. Funk JL. Disorders of the endocrine pancreas. In: McPhee SJ, Hammer GD (eds). Pathophysiology of Disease: An Introduction to Clinical Medicine. 7th ed. New York, NY: McGraw Hill; 2014: 317-544.
46. Rx List, Inc. Amaryl Tablets. Available athttps://www.rxlist.com/amaryl-drug.htm. Last accessed February 6, 2023.
47. Pfeiffer AFH. Oral hypoglycemic agents: sulfonylureas and meglitinides. In: Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008: 97-106.
48. Lipska KJ1, Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013;36(11):3535-3542.
49. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28(12):2948-2961.
50. 50. Springhouse (ed). Nursing 2021 Drug Handbook. Philadelphia, PA: Lippincott, Williams & Wilkins; 2022.
51. Walsh J, Roberts R. Letter to the editor: a study that glucose control can be achieved in 31 type 1 patients who follow a controlled diet and use an insulin pump that is programmed. J Diabetes Sci Technol. 2007;1(4):L3-L6.
52. Kulkarni K. Diets do not fail: the success of medical nutrition therapy in patients with diabetes. Endocr Pract. 2006;12 (Suppl 1):121-123.
54. International Diabetes Federation. Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes. Available athttps://www.idf.org/e-library/guidelines/85-self-monitoring-of-blood-glucose-in-non-insulin-treated-type-2-diabetes.html. Last accessed February 6, 2023.
55. U.S. Food and Drug Administration. FDA Approves First Automated Insulin Delivery Device for Type 1 Diabetes. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-first-automated-insulin-delivery-device-type-1-diabetes. Last accessed February 6, 2023.
56. 56. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care. 2004;27(Suppl 1):S110.
57. Schuler G, Linke A. Diabetes and exercise. In: Goldstein BJ, Müller-Wieland D (eds). Type 2 Diabetes: Principles and Practice. 2nd ed. New York, NY: Informa Healthcare; 2008: 73-82.
58. Steil CF. Pharmacological therapies for glucose management. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
60. Venes D (ed). Taber's Cyclopedic Medical Dictionary. 24th ed. Philadelphia, PA: FA Davis Co.; 2021.
61. 61. Hinnen DA, Childs BP, Guthrie DW, Guthrie RA, Martin SD. Combating clinical inertia with pattern management. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
62. Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(Suppl 1):S144-S153.
63. McLaughlin S. Facilitating successful self-management. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
64. Cryer PE. Exercise-related hypoglycemia-associated autonomic failure. Diabetes. 2009;58(9):1951-1952.
65. Banion C, Valentine V. Type 1 diabetes throughout the life span. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
67. U.S. Food and Drug Administration. FDA Approves First Treatment for Severe Hypoglycemia that Can Be Administered Without an Injection. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-severe-hypoglycemia-can-be-administered-without-injection. Last accessed February 6, 2023.
68. Reaven PD, Emanuele NV, Wiitala WL, et al. Intensive glucose control in patients with type 2 diabetes—15-year follow-up. N Engl J Med. 2019;380:2215-2224.
69. Rhee TJ, Westberg SM, Harris IM. Complementary and alternative medicine in U.S. adults with diabetes: reasons for use and perceived benefits. J Diabetes. 2018;10(4):310-319.
70. LexiComp Online. Available athttps://online.lexi.com. Last accessed February 6, 2023.
71. Foley H, Steel A, Cramer H, et al. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Sci Rep. 2019;9:1573.
1. Academy of Nutrition and Dietetics. Diabetes Type 1 and 2: Evidence-Based Nutrition Practice Guideline. Chicago, IL: Academy of Nutrition and Dietetics; 2015. Available at https://www.andeal.org/topic.cfm?menu=5305&cat=5595. Last accessed February 19, 2023.
Mention of commercial products does not indicate endorsement.